Dinsmore; Christopher
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dinsmore; Christopher.The latest application filed is for "inhibiting fatty acid synthase (fasn)".
- Dinsmore; Christopher - Newton MA
- Dinsmore; Christopher - Schwenksville PA
| Patent | Date |
|---|---|
| Inhibiting fatty acid synthase (FASN) Grant 11,299,484 - Martin , et al. April 12, 2 | 2022-04-12 |
| Inhibiting Fatty Acid Synthase (fasn) App 20210024508 - Martin; Matthew W. ; et al. | 2021-01-28 |
| Inhibiting fatty acid synthase (FASN) Grant 10,875,848 - Martin , et al. December 29, 2 | 2020-12-29 |
| Inhibiting Fatty Acid Synthase (fasn) App 20200115368 - Martin; Matthew W. ; et al. | 2020-04-16 |
| Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors Grant 10,072,025 - Scott , et al. September 11, 2 | 2018-09-11 |
| Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors Grant 10,059,705 - Dinsmore , et al. August 28, 2 | 2018-08-28 |
| N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors Grant 9,957,265 - Dinsmore , et al. May 1, 2 | 2018-05-01 |
| Ethyl N-boc Piperidinyl Pyrazolo Pyridones As Janus Kinase Inhibitors App 20170240567 - Scott; Mark E. ; et al. | 2017-08-24 |
| Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors Grant 9,725,445 - Childers , et al. August 8, 2 | 2017-08-08 |
| Substituted pyrrolopyrimidines as HDM2 inhibitors Grant 9,637,493 - Dinsmore , et al. May 2, 2 | 2017-05-02 |
| 2,6,7,8 substituted purines as HDM2 inhibitors Grant 9,540,377 - Cammarano , et al. January 10, 2 | 2017-01-10 |
| Cycloalkyl Nitrile Pyrazolo Pyridones As Janus Kinase Inhibitors App 20160280704 - Childers; Matthew Lloyd ; et al. | 2016-09-29 |
| N-(2-cyano Heterocyclyl) Pyrazolo Pyridones As Janus Kinase Inhibitors App 20160272633 - Dinsmore; Christopher ; et al. | 2016-09-22 |
| Acyclic Cyanoethylpyrazolo Pyridones As Janus Kinase Inhibitors App 20160272634 - Dinsmore; Christopher ; et al. | 2016-09-22 |
| 2,6,7,8 Substituted Purines As Hdm2 Inhibitors App 20150353553 - Cammarano; Carolyn Michele ; et al. | 2015-12-10 |
| Substituted Pyrrolopyrimidines As Hdm2 Inhibitors App 20150329548 - Dinsmore; Christopher ; et al. | 2015-11-19 |
| Azaindoles as Janus kinase inhibitors Grant 9,096,598 - Butcher , et al. August 4, 2 | 2015-08-04 |
| Pyrrolopyrimidines as janus kinase inhibitors Grant 8,993,756 - Ahearn , et al. March 31, 2 | 2015-03-31 |
| Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors Grant 8,962,608 - Brubaker , et al. February 24, 2 | 2015-02-24 |
| Pyrrolopyrimidines As Janus Kinase Inhiitors App 20140349998 - Ahearn; Sean P ; et al. | 2014-11-27 |
| Azaindoles As Janus Kinase Inhibitors App 20140303142 - Butcher; John W. ; et al. | 2014-10-09 |
| Cycloalkylnitrile Pyrazole Carboxamides As Janus Kinase Inhibitors App 20140243309 - Brubaker; Jason ; et al. | 2014-08-28 |
| Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 Grant 8,329,722 - Siu , et al. December 11, 2 | 2012-12-11 |
| Pyrazolo [3,4-b] Pyridin-4-one Kinase Inhibitors App 20120220624 - Siu; Tony ; et al. | 2012-08-30 |
| Inhibitors Of Janus Kinases And/or 3-phosphoinositide-dependent Protein Kinase-1 App 20100160309 - Siu; Tony ; et al. | 2010-06-24 |
| Inhibitors of farnesyl-protein transferase Grant 6,248,756 - Anthony , et al. June 19, 2 | 2001-06-19 |
| Inhibitors of farnesyl-protein transferase Grant 5,780,488 - Bergman , et al. | 1998-07-14 |
| SEC | 0001826766 | Dinsmore Christopher |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 